Abstract
Background: Patients with epidermal growth factor receptor (EGFR )-sensitive mutations have great opportunity to benefit from EGFR-tyrosine kinase inh......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
